Chemical Structure (Nourianz 01)
Nourianz Tablet, Film Coated
Product Images NDC 42747-604
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nourianz (NDC 42747-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Kyowa Kirin, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (20 mg Tablet Bottle Label)
NOURIANZ® is a professional sample and not for sale medication with istradefylline as the active substance. It is administered orally, with each tablet having 20 mg of istradefylline. The manufacturer is Gyowa KIRIN. The recommended dosage is to be found in the prescribing information. It should be stored between 20°C and 25°C, and kept out of children's reach.*
Principal Display Panel (40 mg Tablet Bottle Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
